Prognostic factors | TRANSBIG | |||
---|---|---|---|---|
 | TDM at 5yrs | TDM at 10 yrs | ||
 | Node- | Node-/ER+ | Node- | Node-/ER+ |
202705_at(CCNB2) | 0.74 | 0.83 | 0.72 | 0.80 |
209642_at(BUB1) | 0.71 | 0.81 | 0.70 | 0.78 |
204962_s_at(CENPA) | 0.69 | 0.84 | 0.69 | 0.79 |
203362_s_at(MAD2L1) | 0.68 | 0.75 | 0.67 | 0.71 |
202095_s_at(BIRC5) | 0.67 | 0.78 | 0.65 | 0.74 |
210074_at(CTSL2) | 0.65 | 0.64 | 0.65 | 0.64 |
209803_s_at(PHLDA2, TSSC3) | 0.61 | 0.62 | 0.59 | 0.61 |
202338_at (TK1) | 0.61 | 0.69 | 0.60 | 0.64 |
204086_at(PRAME) | 0.61 | 0.62 | 0.57 | 0.58 |
202218_s_at (FADSD6) | 0.50 | 0.49 | 0.50 | 0.45 |
210096_at(CYP4B1) | 0.71 | 0.78 | 0.70 | 0.74 |
205883_at(ZNF145) | 0.69 | 0.75 | 0.66 | 0.71 |
219197_s_at(SCUBE2, CEGP1) | 0.66 | 0.66 | 0.63 | 0.59 |
214053_at(ERBB4) | 0.66 | 0.72 | 0.67 | 0.74 |
208305_at(PGR) | 0.65 | 0.66 | 0.64 | 0.66 |
219682_s_at(TBX3) | 0.63 | 0.66 | 0.63 | 0.65 |
204541_at(SEC14L2) | 0.63 | 0.65 | 0.62 | 0.59 |
206091_at(MATN3) | 0.61 | 0.55 | 0.61 | 0.56 |
202554_s_at(GSTM3) | 0.60 | 0.62 | 0.58 | 0.59 |
219440_at(RAI2) | 0.59 | 0.59 | 0.56 | 0.56 |
Our 20-gene signature | 0.73 | 0.83 | 0.70 | 0.79 |
16-gene signature | 0.71 | 0.79 | 0.69 | 0.73 |
70-gene signature | 0.68 | NA | NA | NA |
Nottingham Prognostic Index Score | 0.67 | 0.68 | 0.66 | 0.66 |
Adjuvant! Online 10 year OS prob. | 0.66 | 0.64 | 0.67 | 0.63 |
76-gene signature | 0.65 | 0.68 | 0.62 | 0.64 |
Tumor grade | 0.64 | 0.63 | 0.62 | 0.62 |
Tumor Size | 0.63 | 0.65 | 0.63 | 0.64 |
212021_s_at(MKI67) | 0.62 | 0.70 | 0.65 | 0.70 |
205225_at (ESR1) | 0.58 | 0.59 | 0.57 | 0.61 |
Age | 0.53 | 0.47 | 0.52 | 0.51 |